Infectious Disease

Tissue-type plasminogen activator could help patients critically ill with COVID-19 avoid the need for a ventilator or get them off sooner, a new research paper concludes.

The convalescent plasma may contain antibodies to the virus that causes COVID-19 that will make it easier for infected patients to recover.

A retail pharmacist at a Florida health system provides a view of the COVID-19 pandemic from his front line and suggests ways forward.

Extra precautions before and after the workday and while at home will help HCPs limit risk to family of potential exposure to COVID-19. Guidance here from the AAFP.

Nearly half of US primary care practices are not able to test for COVID-19 and do not have adequate personal protective equipment. Here is what your colleagues are saying.

The latest COVID-19 data on confirmed cases, deaths, and more from the Johns Hopkins COVID-19 interactive map.

The COVID-19 pandemic has made the words "isolation" and quarantine" part of daily conversation. How do you explain them to your patients?

In order to conserve clincal resources needed to care for patients with COVID-19, the American College of Cardiology suggests that a variety of procedures and visits be placed on hold.

How many cases of COVID-19 have been confirmed worldwide? How many in the US? Find out in this quick update.

In repsonse to the COVID-19-related surge in demand for alcohol-based hand sanitizer, the FDA has issued guidance on temporary production and compounding. 

Does COVID-19 cause lasting consequences in patients with chronic lung disease? The answer to this and other common FAQs from these patients provided by the American Lung Association.

Frontline medical workers dealing with COVID-19 in China have a high risk of developing symptoms of depression, anxiety, insomnia, and distress.

The FDA announced that it will take no action against any party for failure to adhere to REMS during the the SARS-CoV-2 public health emergency.

The guidance allows non-medical device manufacturers to produce ventilator parts, hospitals to use ventilators intended for other environments, and more.

A review of US patients with COVID-19 showed that 20% of hospitalizations occurred among adults aged 20-44 years.

There are more than 80 clinical trials in progress globally to test treatments and vaccines targeting COVID-19. We highlight 10 here.

A new study reports that coronavirus remains viable in aerosol for up to 3 hours, a finding that could help inform theories of contagion.

Refresh your memory of the week's top headlines on the COVID-19 pandemic with our 5-question pop quiz.

Digestive symptoms can be added to the list of primary complains associated with COVID-19, a new study from China suggests.

An investigational vaccine against coronavirus disease was administered to the first participant in the country's first clinical trial of an agent to prevent COVID-19 infection.

A new joint statement from the AHA, HFSA, and ACC urge physicians to continue treatment with ACE-i or ARBs in patients with COVID-19.

New research from Columbia University showed undocumented cases of COVID-19 were responsible for over two-thirds of documented infections in China.

The American Diabetes Association warns that COVID-19 may cause severe complications in patients with diabetes. Here’s how you can help.

Rx.Health is creating a digital toolkit for hospitals to aid in easier screening and virtual care for COVID-19. 

In a press release today, the FDA announced 2 significant actions it is taking to combat the widespread coronavirus outbreak.

How many people have died from coronavirus? How is coronavirus spread? The CDC suggests answers to these and other common questions patients may be asking.

How much do you know about syphilis prevention, screening, and treatment? Test yourself with these 5 true or false questions.

Are you up-to-date on the latest infectious disease research? Find out with these 9 catching questions. 

All adults starting at age 18 should be screened for hepatitis C, according to newly released recommendations from the US Preventive Services Task Force.

The first clinical trial in the US to evaluate an experimental treatment for coronavirus disease in humans is now underway at the University of Nebraska.